Search Results - "Badran, Ahmed Ali"

Ribociclib-Induced Pneumonitis: A Case Report by Algwaiz, Ghada, Badran, Ahmed Ali, Elshenawy, Mahmoud A., Al-Tweigeri, Taher

“…Background: Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have been a significant breakthrough in the management of hormone receptor-positive, HER2-negative…”
Get full text

Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs by Suleman, Kausar, Mushtaq, Ali Hassan, Haque, Emaan, Badran, Ahmed Ali, Ajarim, Dahish, Elashwah, Ahmed Mohammed, Gad, Ahmed Mostafa, Abdelsamad, Amgad Shaheen, Omar, Ayman, Khan, Khurshid Ahmed, Al-Tweigeri, Taher, Elshentenawy, Ayman, Alsayed, Adher

“…Introduction: Human epidermal growth factor receptor 2 (HER-2) targeted therapy regimens can improve tumor response in HER-2-positive metastatic breast cancer…”
Get full text

Simultaneous determination of four food allergens using compact disc immunoassaying technology by Badran, Ahmed Ali, Morais, Sergi, Maquieira, Ángel

“…A multiplex competitive microimmunoassay for the simultaneous determination of gliadin, casein, β-lactoglobulin, and ovalbumin is presented. The assay in…”
Get full text

Resectability rate of pancreatic cancer after neoadjuvant therapy by Aljubran, Ali H, Alata, Maaz Kamal, Badran, Ahmed Ali, Alshamsan, Bader, Alnemary, Yasir, Bazarbashi, Shouki, Al Zahrani, Ahmad, Mohamad, Sherif, Mahrous, Mervat, Elshenawy, Mahmoud Abdelsatar

“…e16348 Background: Pancreatic Cancer is one of the leading causes of cancer death in Saudi Arabia. Surgery is the mainstay of treatment in resectable…”
Get full text

Patient's characteristics and outcome of small bowel adenocarcinoma in Saudi Arabia by Alshamsan, Bader I, Badran, Ahmed ali, Aseafan, Mohamed, Shaheen, Amgad, Elshenawy, Mahmoud Abdelsatar, Aljubran, Ali H

“…Abstract only e16277 Background: Small bowel adenocarcinoma (SBA) is a rare disease. We aim to describe patient's characteristics and clinical outcomes among…”
Get full text

Combined alternating sunitinib and bevacizumab in the management of advanced renal cell carcinoma: A phase I/II trial by Bazarbashi, Shouki, Alzahrani, Ahmed M, Aljubran, Ali H, Elshenawy, Mahmoud Abdelsatar, Mostafa Gad, Ahmed, Maraiki, Fatma, Alzannan, Noura, Elhassan, Tusneem, Badran, Ahmed Ali

“…665 Background: Tyrosine kinase inhibitors remain a corner stone in the management of metastatic clear cell renal cell carcinoma (RCC). The intermittent…”
Get full text

Efficacy and toxicity of trastuzumab emtansine among patients with HER-2-positive metastatic breast cancer in Saudi Arabia by Badran, Ahmed Ali, Fallatah, Waleed, Hinkston, Abdullaah Khaleel, Arabi, Tarek, Algwaiz, Ghada, Elshenawy, Mahmoud Abdelsatar, Elshentenawy, Ayman, Haque, Emaan Ul, Twegieri, Taher, Akhtar, Saad, Alsayed, Adher, Ajarim, Dahish Saed, Alzahrani, Meshari, Alaklabi, Sabah, Elhassan, Tusneem, Suleman, Kausar

“…e13001 Background: Trastuzumab emtansine (T-DM1) significantly prolongs progression-free survival (PFS) with a safe drug profile in advanced HER-2-positive…”
Get full text

Metaplastic breast cancer: Disease characteristics and outcome in Arab women by Alsayed, Adher, Alshamsan, Bader I, Alshibany, Aisha, Elshenawy, Mahmoud Abdelsatar, Badran, Ahmed ali, Al-Tweigeri, Taher, Ajarim, Dahish Saed, Suleman, Kausar

“…Abstract only e12534 Background: Metaplastic breast cancer (MPBC) accounts for less than 1% of all breast cancer subtypes. Methods: Patients diagnosed with…”
Get full text

Outcome of preoperative concurrent radiation and infusional gemcitabine in locally advanced rectal cancer, a phase 2 trial by Bazarbashi, Shouki, Gad, Ahmed Mostafa, Badran, Ahmed Ali, Elshenawy, Mahmoud, Aljubran, Ali H, Al Zahrani, Ahmad, Al Manae, Hadeel, Alsuhaibani, Abdullah, Elashwah, Ahmed, Neimatallah, Mohammed, Abdul Jabbar, Alaa, Ashari, Luai, Al Homoud, Samar, Ghebeh, Hazem, Alsanea, Nasser, Mohiuddin, Mohammed

“…Abstract only 94 Background: The achievement of a pathological complete response with preoperative concurrent chemoradiotherapy in locally advanced rectal…”
Get full text

The outcome of vincristine, dactinomycin D, ifosfamide and doxorubicin (VAIA) as first-line therapy for adult-patients with metastatic ewing sarcoma; a single-center experience by Atallah, Jean Paul, Elshenawy, Mahmoud Abdelsatar, Badran, Ahmed ali, Alata, Maaz Kamal, Gad, Ahmed, Alharbi, Abdulrahaman H., Alquaydheb, Hisham N., Alshamsan, Bader I

“…Abstract only e23501 Background: Ewing sarcoma family of tumors (ESFT) is a rare malignancy among adults. Most studies from western countries have reported…”
Get full text

Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy +/- intraoperative radiation therapy in the management of peritoneal sarcomatosis: Real world experience by Badran, Ahmed ali, Elashwah, Ahmed, Elshenawy, Mahmoud Abdelsatar, Azzam, Ayman, Alshibani, Aisha, Alrakaf, Reem, AbdelRehem, Rania Naguib, Eldali, Abdelmoniem, Amin, Tarek

“…Abstract only e23581 Background: Sarcomas are aggressive malignancy,30-40% of them originate from retroperitoneal space. which makes adequate free surgical…”
Get full text

Combination of everolimus and lu-177 PRRT in treatment of G1-2 neuroendocrine tumors (NET): Phase 1-2 study by Aljubran, Ali Husain, Alrowaili, Mohamed, Raef, Hussein, Bazarbashi, Shouki, Alzahrani, Ahmed M, Almuhaideb, Ahmed, Almanea, Hadeel, Badran, Ahmed ali, Al-Dalee, Abdelmuniem, Tuli, Mahmoud

“…Abstract only 386 Background: Everolimus and Lutetium-177 PRRT were approved as monotherapy. However, animal model research showed synergistic effect of the…”
Get full text